Q&A

In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...

At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...

In a recent presentation at Practical Updates in Primary Care, Joel M. Gelfand, MD, provided an overview of psoriasis care for primary care providers alongside co-presenter Annie Truss, MD. In this...

Veteran dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares practical insights on how he incorporates ZORYVE® (roflumilast) into the treatment of atopic dermatitis, seborrheic...

Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...

Junaid Anwar, MD, discusses a meta-analysis of five landmark trials evaluating Janus kinase inhibitors for myelofibrosis, highlighting first-line efficacy and tolerability with ruxolitinib, second-line...

Shanti Eswaran, MD, and Joel Heidelbaugh, MD, share evidence-based strategies to help primary care clinicians diagnose and manage IBS and chronic constipation with confidence.

Matthew B. Carroll, MD, MACP, FACR, discusses his ACP Internal Medicine Meeting presentation on four foot and ankle conditions frequently seen in primary care. He shares clinical considerations for initial...

Samiya Khan, MD, examines the national impact of social isolation on diabetes prevalence and glycemic control in aging populations, presenting key findings from a cross-sectional study at ENDO 2025, July...

The team behind SMART, an AI-powered web application for diabetic retinopathy detection, discusses the development, validation, and clinical relevance of a lightweight, privacy-conscious screening model...